Table 4 Sociodemographic, anthropometric and sports characteristics, and clinical history of COVID-19 of study participants.
Characteristics | Participants (n=20) | CG (n=10) | ||
|---|---|---|---|---|
Sociodemographic characteristics | ||||
Age (years) | 35.7 ± 11.3 | 36.6 ± 11.5 | ||
Gender, n (%) | Man | 20.0 (100.0) | 10.0 (100.0) | |
Women | 0.0 (0.0) | 0.0 (0.0) | ||
Ethnicity, n (%) | Caucasian | 20.0 (100.0) | 10.0 (100.0) | |
Other | 0.0 (0.0) | 0.0 (0.0) | ||
Anthropometric parameters | ||||
Body mass (kg) | 77.6 ± 10.9 | 78.3 ± 10.6 | ||
Fat mass (kg) | 9.7 ± 2.9 | 9.8 ± 2.8 | ||
Fat mass (%) | 12.5 ± 2.3 | 12.7 ± 2.6 | ||
Fat free mass (kg) | 67.9 ± 4.1 | 67.5 ± 3.9 | ||
Fat free mass (%) | 65.2 ± 2.6 | 65.1 ± 2.4 | ||
Height (cm) | 171.5 ± 5.6 | 173.2 ± 5.4 | ||
Sports parameters | ||||
CrossFit® experience (months) | 35.3 ± 11.7 | 36.7 ± 11.9 | ||
Fran WODs 1 * (s) | 231.0 ± 15.0 | 235.0 ± 12.0 | ||
COVID-19 clinical history | ||||
SARS-CoV-2 Infection 2 *, n (%) | 0 | 4 (20.0) | 1 (10.0) | |
1 | 9 (45.0) | 5 (50.0) | ||
2 | 6 (30.0) | 4 (40.0) | ||
3 | 1 (5.0) | 0 (0.0) | ||
Symptoms | Cough, n/% | 9 / 45% | 5 / 50% | |
Dyspnea, n/% | 7 / 35% | 3 / 30% | ||
Ageusia and anosmia, n/% | 15 / 75% | 8 / 80% | ||
Fever, n/% | 8 / 40% | 3 / 30% | ||
Myalgia, n/% | 9 / 45% | 9 / 90% | ||
Perception of symptom severity (0-3) 3 | 1.8 ± 0.2 | 1.9 ± 0.2 | ||
COVID-19 Vaccine | 20.0 (100.0) | 10.0 (100.0) | ||
